Viral hepatitis B in patients with hematological malignancies (Overview)-Reference-Cited by-同舟云学术

Viral hepatitis B in patients with hematological malignancies (Overview)

Published:2023-01-30 Issue:1 Volume:9 Page:001-004
ISSN:2641-2977
Container-title:Archives of Hepatitis Research
language:
Short-container-title:Arch Hepat Res

Author:

SV Sidorkevich,VN Chebotkevich,AV Kuleshova,EI Kajtandzhan,SS Bessmeltsev

Abstract

The review presents current data on the role of viral hepatitis B in oncohematological patients. Possible ways of infection, prevention of infection, and activation of hepatitis B in this category of patients are considered. The specific features of the course of hepatitis B in various clinical situations are described: against the background of other viral infections and in the conduct of specific anti-leukemia therapy.

Publisher

Peertechz Publications Private Limited

Subject

General Medicine

Reference21 articles.

1. 1. Bessmeltsev SS, Abdulkadyrov KM. Multiple Myeloma: Guidelines for Physicians. Moscow: МК, 2016; 504. (In Russ.)].

2. Hepatitis B and C virus infection and risk of hematological malignancies;Marrone;J Viral Hepat,2020

3. 3. Panasyuk YaV, Vlasenko NV, Churilova NS. The dynamics of the incidence of chronic hepatitis B in the Russian Federation and individual federal districts for the period from 2009-2020. In the book: Infectious Diseases in the Modern World: Evolution, Current and Future Threats. Proceedings of the XIV Annual All-Russian Congress on Infectious Diseases named after Academician V.I. Pokrovsky. Moscow, 2022; 131-132.

4. 4. Bessmeltsev SS, Romanenko NA. Anemia in tumorous diseases of the blood system: a guide for doctors: Guidelines for Physicians. Moscow: Special Publishing House of Medical Books, 2017.

5. Viral hepatitis B in patients with hematological malignancies (overview);Chebotkevich;Gournal Infectologii,2017